Ignite Creation Date:
2025-12-24 @ 11:05 PM
Ignite Modification Date:
2026-02-06 @ 8:59 AM
Study NCT ID:
NCT04672369
Status:
COMPLETED
Last Update Posted:
2023-06-22
First Post:
2020-12-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced NSCLC
Sponsor:
Innovent Biologics (Suzhou) Co. Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Lung Cancer | View |
Keywords: